Literature DB >> 28440333

Immunotherapy: Cul-TIL-vating uveal melanoma regression.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28440333     DOI： 10.1038/nrclinonc.2017.61

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

Authors:  Smita S Chandran; Robert P T Somerville; James C Yang; Richard M Sherry; Christopher A Klebanoff; Stephanie L Goff; John R Wunderlich; David N Danforth; Daniel Zlott; Biman C Paria; Arvind C Sabesan; Abhishek K Srivastava; Liqiang Xi; Trinh H Pham; Mark Raffeld; Donald E White; Mary Ann Toomey; Steven A Rosenberg; Udai S Kammula
Journal:  Lancet Oncol       Date:  2017-04-07       Impact factor: 41.316
  1 in total
  1 in total

Review 1.  Recent Advances and Challenges in Uveal Melanoma Immunotherapy.

Authors:  Yihang Fu; Wei Xiao; Yuxiang Mao
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.